Semaglutide & Tirzepatide Side Effects: What to Expect and How to Manage Them

Most people starting a GLP-1 medication experience some side effects, especially in the first weeks. Knowing what’s normal, what’s not, and how dose titration drives the experience can make the difference between staying on treatment and quitting early. Here is a practical, evidence-aligned overview.

Why side effects happen

Semaglutide and tirzepatide slow gastric emptying and act on appetite centers. That mechanism is also why the most common side effects are gastrointestinal — the gut is adjusting to slower digestion. Because the effect scales with dose, symptoms are typically worst right after each dose increase and ease as your body adapts. This is the central reason GLP-1s are titrated up slowly rather than started at full strength.

The common side effects

The most frequently reported, shared across both molecules:

• Nausea — the most common, usually mild to moderate, worst early.
• Diarrhea and constipation — often alternating.
• Vomiting — less common, more likely with faster titration.
• Fatigue, headache, burping — usually transient.

These typically diminish over days to weeks at a stable dose.

Practical management strategies

Approaches clinicians commonly recommend (discuss with your own provider):

• Eat smaller, slower meals. A full stomach on top of slowed emptying drives nausea.
• Favor bland, lower-fat foods during dose increases; very fatty meals tend to worsen symptoms.
• Hydrate — diarrhea and reduced intake can dehydrate you, which worsens fatigue and headache.
• Don’t rush titration. If a dose increase hits hard, a slower schedule often helps — a conversation for your prescriber. Flat-pricing providers make this easier because slowing down doesn’t change your cost.
• Time the dose to your week so the first day or two (often the roughest) lands when you can rest.

The serious risks to know

Less common but important, per the brand labels:

• Gallbladder problems (gallstones, inflammation), more likely with rapid weight loss.
• Pancreatitis — seek care for severe, persistent abdominal pain.
• Thyroid C-cell tumor boxed warning — based on rodent studies; these drugs are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
• Kidney issues from dehydration due to severe vomiting/diarrhea.

These apply to the molecule and therefore to compounded versions too. They are reasons to stay under the care of a licensed prescriber rather than self-managing.

A note specific to compounded products

Compounded GLP-1s are often supplied as multi-dose vials, which means you measure each dose. Dosing errors from miscalculation are a documented cause of adverse events — the FDA logged hundreds of reports, some requiring hospitalization. If you use a compounded product, make sure your provider gives unambiguous dosing instructions, and never guess. This is one more reason to choose a provider with strong clinical support; see our verification checklist.

When to call your provider

Contact a clinician promptly for severe or persistent abdominal pain, signs of dehydration, persistent vomiting, or any symptom that feels out of proportion. Don’t stop the medication abruptly on your own without guidance.

Bottom line

Most GLP-1 side effects are gastrointestinal, dose-dependent, and manageable with slower titration, smaller meals, and hydration. Serious risks are uncommon but real, which is why ongoing prescriber oversight matters — especially with compounded multi-dose vials where dosing accuracy is on you.

This is a sensitive health topic. Educational, not medical advice. Consult a licensed clinician about your specific situation.